Structural studies of nucleic acid sensing Toll-like receptors
Project/Area Number |
25291010
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Structural biochemistry
|
Research Institution | The University of Tokyo |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥18,070,000 (Direct Cost: ¥13,900,000、Indirect Cost: ¥4,170,000)
Fiscal Year 2015: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2014: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥7,670,000 (Direct Cost: ¥5,900,000、Indirect Cost: ¥1,770,000)
|
Keywords | Toll様受容体 / 自然免疫 / X線結晶解析 / 一本鎖核酸 / 1本鎖核酸 / X線結晶構造解析 / X線結晶構造解析 |
Outline of Final Research Achievements |
Innate immunity serves as the first line of defense against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR8 recognizes single stranded (ss) RNA derived from bacterial and viral DNA. We solved the crystal structure of TLR8 in complex with ssRNA and revealed that TLR8 is a uridine senso. TLR8 can be synergistically activated by uridine and oligonucleotide degraded from ssRNATLR9 recognizes bacterial and viral DNA containing the Cytosine-phosphate-Guanine (CpG) dideoxynucleotide motif. Here we show the crystal structure of TLR9 bound to agonistic CpG-DNA, forming a symmetric TLR9/CpG-DNA complex with 2:2 stoichiometry. CpG-DNA was recognized by both protomers in the dimer, in particular by the N-terminal fragment (LRRNT-LRR10) from one protomer and the C-terminal fragment (LRR20-LRR22) from the other.
|
Report
(4 results)
Research Products
(17 results)
-
-
[Journal Article] Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.2015
Author(s)
Ohto, U., Shibata, T., Tanji, H., Krayukhina, E., Uchiyama, S., Miyake, K., and Shimizu, T.
-
Journal Title
Nature
Volume: 520
Issue: 7549
Pages: 702-705
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
[Journal Article] Targeting cell surface TLR7 for therapeutic intervention in autoimmune diseases2015
Author(s)
Kanno A, Tanimura N, Ishizaki M, Ohko K, Motoi Y, Onji M, Fukui R, Shimozato T, Yamamoto K, Shibata T, Sano S, Sugahara-Tobinai A, Takai T, Ohto U, Shimizu T, Saitoh S, Miyake K.
-
Journal Title
Nature Communications
Volume: 6
Issue: 1
Pages: 6119-6119
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Structure-based Design of Human TLR8-specific Agonists with Augmented Potency and Adjuvanticity.2015
Author(s)
Beesu, M., Caruso, G., Salyer, A., Khetani, K., Sil, D., Weerasinghe, M., Tanji, H., Ohto, U., Shimizu, T., & David, S. A.
-
Journal Title
J. Med. Chem.
Volume: 58
Issue: 19
Pages: 7833-7849
DOI
Related Report
Peer Reviewed / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
[Journal Article] Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A2013
Author(s)
N. Yamakawa, U. Ohto, S. Akashi-Takamura, K. Takahashi, SI. Saitoh, N. Tanimura, T. Suganami, Y. Ogawa, T. Shibata, T. Shimizu, K. Miyake
-
Journal Title
Int. Immunol.
Volume: 25
Issue: 1
Pages: 45-52
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-